Growth-Promoting Therapies May Be Useful In Short Stature Patients With Nonspecific Skeletal Abnormalities Caused By Acan Heterozygous Mutations: Six Chinese Cases And Literature Review
- 1 November 2020
- journal article
- review article
- Published by Elsevier BV in Endocrine Practice
- Vol. 26 (11), 1255-1268
- https://doi.org/10.4158/ep-2019-0518
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Pathogenic gene screening in 91 Chinese patients with short stature of unknown etiology with a targeted next-generation sequencing panelBMC Medical Genetics, 2018
- Genetic short statureGrowth Hormone & IGF Research, 2018
- Etiologies of short stature in a pediatric endocrine clinic in Southern ThailandJournal of Pediatric Endocrinology and Metabolism, 2017
- Challenges in the Management of Short StatureHormone Research in Paediatrics, 2015
- Etiologies and characteristics of children with chief complaint of short statureAnnals of Pediatric Endocrinology & Metabolism, 2015
- Aggrecan: Approaches to Study Biophysical and Biomechanical PropertiesMethods in Molecular Biology, 2014
- The role of aggrecan in normal and osteoarthritic cartilageJournal of Experimental Orthopaedics, 2014
- A Recessive Skeletal Dysplasia, SEMD Aggrecan Type, Results from a Missense Mutation Affecting the C-Type Lectin Domain of AggrecanAmerican Journal of Human Genetics, 2009
- Identification of a locus for a form of spondyloepiphyseal dysplasia on chromosome 15q26.1: exclusion of aggrecan as a candidate geneJournal of Medical Genetics, 2002
- Structure of the human aggrecan gene: exon-intron organization and association with the protein domainsBiochemical Journal, 1995